Ƙarar ƙa'idar Orlistat (96829-58-2)

Oktoba 30, 2018

Raw Orlistat foda magani ne da ake amfani dashi don kula da kiba. Babban aikinta shine hana shan kitse daga abincin mutum human.


Status: A Mass Production
Naúra: 25kg / Drum
Capacity: 1470kg / watan

Rafin kolistat foda (96829-58-2) bidiyo

Ƙarar ƙa'idar Orlistat (96829-58-2)

Raw Orlistat powder is in a class of medications called lipase inhibitors that works by blocking absorption of 25% of the fat in a meal and is used for weight loss in overweight adults, 18 years and older, when used along with a reduced-calorie and low-fat diet. Raw Orlistat powder is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. Raw Orlistat foda works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested. Prescription Raw Orlistat powder is used in overweight people who may also have high blood pressure, diabetes, high cholesterol, or heart disease. The effectiveness of Raw Orlistat powder in promoting weight loss is definite but modest. Pooled data from clinical trials suggest that people given Raw Orlistat powder in addition to lifestyle modifications, such as diet and exercise, lose about 2–3 kilograms (4.4–6.6 lb) more than those not taking the drug over the course of a year.Raw Orlistat powder also modestly reduces blood pressure and appears to prevent the onset of type 2 diabetes, whether from the nauyi asara itself or other effects. It reduces the incidence of diabetes type II in people who are obese around the same amount that lifestyle changes do.

 

Ƙarar ƙa'idar Orlistat (96829-58-2) Bayani

Product Name Raw Orlistat foda
Chemical Name Tetrahydrolipstatin, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl-2-formamido-4-methylvalerate
Brand Name Alli, Xenical
Drug Class masu ƙetare lipase
CAS Number 96829-58-2
InChIKey AHLBNYSZXLDEJQ-FWEHEUNISA-N
Kwayoyin halitta FƘararraki C29H53NO5
Kwayoyin halitta Wtakwas 495.745 g / mol
Monoisotopic Mass 495.392 g / mol
Gyarawa Point  <50 ° C
Freezing Point Babu kwanan wata
Half Half-Life Bisa ga iyakanceccen bayanan, rabin rabi na Raw Orlistat foda yana cikin kewayon 1 zuwa 2 hours.
Launi White foda
solubility  DMSO: 19 MG / ML
Storage Taikin zafi  lokacin ajiya. 2-8 ° C
Aaikace-aikace Yi anfani da kiba.

 

Raw Orlistat foda (96829-58-2) Bayani

Raw Orlistat powder is in a class of medications called lipase inhibitors that works by blocking absorption of 25% of the fat in a meal and is used for nauyi asara in overweight adults, 18 years and older, when used along with a reduced-calorie and low-fat diet.

Raw Orlistat powder is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake. Raw Orlistat foda works by inhibiting pancreatic lipase, an enzyme that breaks down triglycerides in the intestine. Without this enzyme, triglycerides from the diet are prevented from being hydrolyzed into absorbable free fatty acids and are excreted undigested. Prescription Raw Orlistat powder is used in overweight people who may also have high blood pressure, diabetes, high cholesterol, or heart disease. The effectiveness of Raw Orlistat powder in promoting weight loss is definite but modest. Pooled data from clinical trials suggest that people given Raw Orlistat powder in addition to lifestyle modifications, such as diet and exercise, lose about 2–3 kilograms (4.4–6.6 lb) more than those not taking the drug over the course of a year.Raw Orlistat powder also modestly reduces blood pressure and appears to prevent the onset of type 2 diabetes, whether from the weight loss itself or other effects. It reduces the incidence of diabetes type II in people who are obese around the same amount that lifestyle changes do.

Orlistat foda (96829-58-2) Hanyar Ayyuka

Orlistat powder is a type of lipase inhibiting asarar hasara and is a hydrated derivative of lipostatin. Orlistat effectively and selectively inhibits stomach lipase and pancreatic lipase, while having no impact on other digestive enzymes (such as amylase, trypsin and chymotrypsin) and on phospholipase, nor does it affect the absorption of carbohydrates, protein and phospholipids. This drug is not absorbed though the gastrointestinal tract and has a reversible inhibiting effect on lipase. Orlistat deactivates enzymes by covalent binding to the serine residue on the active sites of stomach and pancreatic lipase. This prevents the fat in food from being broken down into free fatty acids and diacylglycerol, so it cannot be absorbed, lowering caloric intake and therefore controlling body weight. This drug does not need to be absorbed by the entire body to take effect. Orlistat’s pharmacological activity is dose dependent: a treatment dosage of Orlistat (120mg/d, tid, taken with meals), combined with a low-calorie diet, can reduce up to 30% of fat absorption. In a study comparing normal and obese volunteers, Orlistat was basically not absorbed by the body at all and had a very low blood concentration. After a single oral dosage (the largest being 800mg), the blood concentration of Orlistat in the following 8 hours was <5 ng/ml. Typically, a treatment dosage of Orlistat is only minimally absorbed by the body and will not accumulate in a short treatment period. In an in vitro experiment, Orlistat’s binding rate with other serum proteins exceeded 99% (bound proteins were mainly lipoproteins and albumin), and its binding rate with red blood cells was very low.

Amfanin Orlistat foda (96829-58-2)

Orlistat yana rage yawan jiki da fiye da 20% a kan kudin mai

Orlista na taimaka muku wajen koyon yadda ake kirga adadin kuzari

L Orlista tana ba ka jin daɗin rayuwa

Orlista yana da kyakkyawan sakamako yana ba da tabbaci da farin ciki ga masu amfani

L Orlista yana ba da sakamako mai ɗorewa na dogon lokaci

Orlista yana rage munin cututtuka kamar su hauhawar jini, ciwon suga, atherosclerosis da

cholesterol.

Tabbatar da Orlistat foda (96829-58-2) Dosage

Ƙwararren shawarar da Orlistat foda yake daya shine 120-mg capsule sau uku a rana tare da kowane abinci mai dauke da mai (a lokacin ko har zuwa 1 awa bayan cin abinci). Ba a nuna alamar sama fiye da 120 MG sau uku a rana ba don ba da ƙarin amfani.

Ya kamata mutane su kasance a kan abinci mai gina jiki, rage yawan kalori wanda ya ƙunshi kusan 30% na adadin kuzari daga mai. Za a rarraba cin abinci na yau da kullum, carbohydrate, da kuma gina jiki a kan manyan abinci guda uku. Idan an ci abinci a wasu lokuta ko kuma ba shi da kitshi, za a iya cire nauyin Orlistat foda.

Saboda an nuna Orlistat foda don rage shan wasu bitamin mai narkewa da kuma betacarotene, yakamata a shawarci mutane da su sha multivitamin dauke da bitamin mai narkewa don tabbatar da isasshen abinci. A gefen, ya kamata a sha ƙarin bitamin aƙalla awanni 2 kafin ko bayan gudanarwar Orlistat foda, kamar lokacin barci.

Hanyoyi na Orlistat foda (96829-58-2)

Yana da kyau a lura side effects of Orlistat powder once you use it. You may experience some of the side effects or not just like after taking any other medication. Most of the effects that come with the use of Orlistat powder are related to the way it functions in your digestive system. They are usually mild and regularly occur when you start the treatment. They also happen after you’ve taken a high-fat meal. Luckily, the majority of them go away as the treatment continues and after following the right diet.

Wadannan su ne wasu sakamako masu tasiri na kowa:

 ciwon kai

 Abun ciki mai zafi / discomfor

 Yarda da fitarwa

 Fatal stools

 M fata rash

 Binciken baya

Beside, if you go through any of these illa, you should treat it as an emergency and call the doctor immediately. They are;

 Babban ciwo mai zafi wanda ba ya tafi.

 Hive ko wuce kima itching

 Difficile haɗiye

 Dama mai wuya